Business
Thermic Science Prepares Form 10 Registration Statement To File First Quarter 2022, Begins 2-Year Audit Current Filings To Become Fully-Reporting Status Meeting the Requirements Of The SEC Exchange Act Of 1934 With Subsequent Up Listings To The OTCQB and
Thermic Science Prepares Form 10 Registration Statement To File First Quarter 2022, Begins 2-Year Audit Current Filings To Become Fully-Reporting Status Meeting the Requirements Of The SEC Exchange Act Of 1934 With Subsequent Up Listings To The OTCQB and.
About this update from Endocan Corp
[{"type":"text","content":"NASHVILLE, TN / ACCESSWIRE / November 23, 2021 / Thermic Science International Corporation, formerly known as Omnicanna Health Solutions, Inc. aka ENDOCAN CORP. (WKN: A1W61J, ISIN: US29271J1097) (OTC:ENDO), is pleased to announce that Thermic Science, working on the filing a Form 10 Registration Statement with the United States Securities and Exchange Commission pursuant to Section 12(g) of the Securities Exchange Act of 1934 and prepare for subsequent up listings to the OTCQB and NASDAQ respectively.The Form 10 filing is a third-party audited statement that provides confirmed information about the Company's current filings and operations, including an overview of the business strategies, risk factors, and financial statements. This ongoing obligation to timely file with the SEC will help all investors make more informed, timely, and educated investment decisions while purchasing the Company shares.Thermic Science President Raymond C. Dabney stated, We've seen this in front of our eyes, and I think if you were to do a common sense comparable, we certainly have a plethora of exciting and proven drug development targets ready to go. This company up listed to NASDAQ on a $4-8 million dollar raise and then raised another $10+ mm subsequently after the up list. Very exciting for us next!Point in case is they did it, and they Motivated us even more by using a "chemical" version of our groundbreaking Natural Cannabinol "CBN Drug Patent" as a Clinical product offering, (similar to the chemical drug Marinol for a chemical THC replacement) this amazes us even more. Our legal team in Europe is ready to negotiate with all possible CBN Patent licensees. This is so exciting for us, as it increases our value dramatically!Check this out:InMed Pharmaceuticals Inc. (INM)NasdaqCM - NasdaqCM Real Time Price. Currency in USDhttps://finance.yahoo.com/news/inmed-pharmaceuticals-announces-commencement-phase-113000535.html*** Many Kudos to one of our "Close Investors" for pointing this out to us! We have lots of info coming in from everywhere, Thanks Guys! And Thanks to our CSi-EDP and Great Team!This up listing fact really motivates us! All this excitement comes from the highly anticipated Cannabis Science Inc., acquisition, Thermic Infrared Heating Paint Product lines, and the advanced Litcoat technology we announced almo...